Sponsor content
155 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPEVIGO spesolimab (rch) 150 mg in 1 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPEVIGO spesolimab (rch) 300 mg in 2 mL solution for injection pre-filled syringe.
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METALYSE tenecteplase (rch) 25 mg powder for injection vial.
-
Prescription medicine registrationActive ingredients: Tenecteplase.
-
Prescription medicine registrationActive ingredients: empagliflozin.
-
Prescription medicine registrationActive ingredients: empagliflozin, metformin hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial.
-
Australian public assessment report (AusPar)Jardiance (empagliflozin) has been approved for reducing the risk of kidney disease progression in adults with chronic kidney disease.